# clm_D99C678FB2C8

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: total_equity  
value: 36,490,000,000 United States dollar  
valid_from: 2022-06-30  
valid_to: 2022-09-30  
published: 2022-08-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2C9B44DDBA52  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories total equity: 36,490,000,000 United States dollar", as of 2022-06-30 (until 2022-09-30). Claim clm_D99C678FB2C8, https://asof.is/claim/clm_D99C678FB2C8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828022020209/0001628280-22-020209-index.htm (primary, SEC EDGAR 10-Q Q2 FY2022, published 2022-08-02)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | total_equity | 35,399,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_D99C678FB2C8](/claim/clm_D99C678FB2C8.md) | [clm_44B2ADC81A66](/claim/clm_44B2ADC81A66.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.